Dog /
FDA CVM · 2025 release 837 reports on file

Alaskan Malamute - FDA Adverse Event Profile

Adverse-event records for Alaskan Malamute (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 64 48 32 16 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Alaskan Malamute drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Among dog breeds, Alaskan Malamute is #116 by FDA report volume; 4.8% of its 837 reports (40) were death-coded.

#116
most-reported dog breed
4.8%
death-coded report share
149
Vomiting - top reaction
5.4 yr
average age at report

Report counts track breed popularity and reporting activity, not real-world risk, read this alongside how common the breed is.

Total Reports

837

FDA CVM filings

Deaths Reported

40

of 837 reports

Death Rate

4.8%

death-coded share

Avg Age at Report

5.4 yr

38.2 kg avg weight

Death-Coded Outcome Share

Alaskan Malamute death-coded reports 4.8%
Cross-breed median

4.8% of 837 alaskan malamute reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 38.2 kg (84.2 lbs)

Top Reported Reactions

Vomiting 149
Lethargy (see also Central nervous system depression in 'Neurological') 99
Diarrhoea 81
Lack of efficacy - NOS 53
Emesis 52
Lack of efficacy (endoparasite) - heartworm 49
Lack of efficacy (endoparasite) - hookworm 45
INEFFECTIVE, HEARTWORM LARVAE 41

Most Referenced Drugs

Milbemycin Oxime + Spinosad 149
Ivermectin + Pyrantel As Pamoate Salt 96
Pyrantel Pamoate;Sarolaner 63
Afoxolaner 61
Milbemycin Oxime + Praziquantel 44
Bedinvetmab 44
Spinosad 32
Fluralaner Chew Tablets 31

Outcome Breakdown

Outcome Unknown
263 (33.5%)
Recovered/Normal
234 (29.8%)
Ongoing
211 (26.9%)
Recovered with Sequela
36 (4.6%)
Died
24 (3.1%)
Euthanized
16 (2.0%)

Gender Distribution

Male 437 (52.2%)
Female 385 (46.0%)
Unknown 11 (1.3%)
Mixed 4 (0.5%)

Reports by Year

Year Reports Trend
2010 23
2011 33
2012 57
2013 59
2014 49
2015 67
2016 61
2017 67
2018 57
2019 64
2020 54
2021 46
2022 46
2023 53
2024 55
2025 46

Alaskan Malamute Pet Health Insights

Alaskan Malamute accounts for 837 FDA adverse event reports, ranking #116 by volume among dog breeds, with 40 reports (4.8%) coded as a death outcome. Mean age at report: 5.4 years, average weight 38.2 kg (84.2 lbs).

Top reported signs: Vomiting (149), Lethargy (see also Central nervous system depression in 'Neurological') (99), Diarrhoea (81). Most-referenced drug: Milbemycin Oxime + Spinosad (149 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (96) and Pyrantel Pamoate;Sarolaner (63).

Outcome coding on 784 status-recorded reports is dominated by Outcome Unknown (33.5%). Annual submissions ranged 2,010-2,025 across 16 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Alaskan Malamute?
There are 837 adverse event reports involving Alaskan Malamute in the FDA database, with 40 reports involving death (4.8% death rate). Alaskan Malamute ranks #116 by report volume.
What are the most common adverse reactions reported for Alaskan Malamute?
The most commonly reported adverse reactions for Alaskan Malamute are Vomiting (149 reports), Lethargy (see also Central nervous system depression in 'Neurological') (99 reports), Diarrhoea (81 reports), Lack of efficacy - NOS (53 reports), Emesis (52 reports).
What drugs are most frequently associated with Alaskan Malamute adverse events?
The drugs most frequently referenced in Alaskan Malamute adverse event reports are Milbemycin Oxime + Spinosad (149 reports), Ivermectin + Pyrantel As Pamoate Salt (96 reports), Pyrantel Pamoate;Sarolaner (63 reports), Afoxolaner (61 reports), Milbemycin Oxime + Praziquantel (44 reports).
What is the average age of Alaskan Malamute in adverse event reports?
The average age of Alaskan Malamute at the time of adverse event reports is 5.4 years, with an average weight of 38.2 kg (84.2 lbs).
Does a high number of adverse event reports mean Alaskan Malamute is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Alaskan Malamute safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.